- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (503)
- Timeline of Article Publication (20)
- Authors Evaluation (3)
- Article Quality Tracking (0)
- Reference Citation Analysis (10)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17949)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2023 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang KY, Wang FY, Lv M, Ma XX, Tang XD, Lv L. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 2023; 29(26): 4120-4135 [PMID: 37475846 DOI: 10.3748/wjg.v29.i26.4120] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4120.htm |
| Number | Citing Articles |
| 1 |
Mohammed Al-Beltagi, Nermin K Saeed, Adel S Bediwy, Reem Elbeltagi. Breaking the cycle: Psychological and social dimensions of pediatric functional gastrointestinal disorders. World Journal of Clinical Pediatrics 2025; 14(2): 103323 doi: 10.5409/wjcp.v14.i2.103323
|
| 2 |
Ploutarchos Pastras, Ioanna Aggeletopoulou, Christos Triantos. Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options. Microorganisms 2024; 12(10): 2036 doi: 10.3390/microorganisms12102036
|
| 3 |
Kaiyue Huang, Mi Lv, Ting Zheng, Fengyun Wang, Xudong Tang, Lin Lv. Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1475366
|
| 4 |
Francisco Idalsoaga, Gustavo Ayares, Hanna Blaney, Daniel Cabrera, Javier Chahuan, Hugo Monrroy, Ayah Matar, Houssam Halawi, Marco Arrese, Juan Pablo Arab, Luis Antonio Díaz. Neurogastroenterology and motility disorders in patients with cirrhosis. Hepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000622
|
| 5 |
Sohel S. Shaikh, Sanjay Kumar. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial. Medicine 2024; 103(31): e39134 doi: 10.1097/MD.0000000000039134
|
| 6 |
Christian Lambiase, Alessandra Rossi, Riccardo Morganti, Lorenzo Cancelli, Antonio Grosso, Riccardo Tedeschi, Francesco Rettura, Marta Mosca, Nicola de Bortoli, Massimo Bellini. Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes. Nutrients 2024; 16(19): 3419 doi: 10.3390/nu16193419
|
| 7 |
Na-Ri Choi, Seok-Jae Ko, Joo-Hyun Nam, Woo-Gyun Choi, Jong-Hwan Lee, Seung-Yeol Nah, Jae-Woo Park, Byung-Joo Kim. Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5. Pharmaceuticals 2024; 17(9): 1170 doi: 10.3390/ph17091170
|
| 8 |
Peicai Li, Yanping Tang, Lei Liu, Lei Yang, Li Yang, Zhongmei Sun, Yanxia Gong. The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03726-0
|
| 9 |
Kimia Shahbazi, Maryam Jameshorani, Amir Mahmoodkhani, Seyedeh Neda Mousavi. Dietary Inflammatory and Glycemic Indices in Newly Diagnosed Irritable Bowel Syndrome Patients Compared to Healthy People: A Case-Control Study. Journal of Human Environment and Health Promotion 2025; 11(1): 19 doi: 10.61186/jhehp.11.1.19
|
| 10 |
Hongxiu Chen, Zhifang Xu, Honggang Zhao, Jiazhen Cao, Rui Wang, Jing He, Ru Nie, Jialin Jia, Shuting Yuan, Yonghong Li, Zhicheng Liu, Xinyu Zhang, Lijuan Ha, Xiaoru Xu, Tie Li. Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01396-y
|
| 11 |
Alessandro Giammona, Bruno Giovanni Galuzzi, Elena Imperia, Clarissa Gervasoni, Sofia Remedia, Laura Restaneo, Martina Nespoli, Laura De Gara, Flaminia Tani, Michele Cicala, Michele Pier Luca Guarino, Danilo Porro, Antonio Cerasa, Alessia Lo Dico, Annamaria Altomare, Gloria Bertoli. Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date. International Journal of Molecular Sciences 2025; 26(1): 413 doi: 10.3390/ijms26010413
|
| 12 |
Alice Sandberg-Janzon, Pontus Karling. Prescription of commonly used drugs in patients with functional bowel disorders. A cross-sectional comparison with the general population. Scandinavian Journal of Gastroenterology 2025; 60(3): 253 doi: 10.1080/00365521.2025.2458070
|
| 13 |
Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, Velia Cassano, Angela Sciacqua, Mohamad Khalil, Piero Portincasa, Leonilde Bonfrate. Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability. European Journal of Internal Medicine 2024; 125: 10 doi: 10.1016/j.ejim.2024.03.011
|
| 14 |
Jean Carlos Fernando Besson, Isadora Carolina Rissi Colombo , Enrique Ayres de Oliveira. SÍNDROME DO INTESTINO IRRITÁVEL NO CONTEXTO DE ESTRESSE CRÔNICO VIVENCIADO PELOS ESTUDANTES DE MEDICINA. Revista Contemporânea 2025; 5(3): e7748 doi: 10.56083/RCV5N3-078
|
| 15 |
Mhd Bashir Almonajjed, Mahdi Wardeh, Abdallah Atlagh, Abdulrahman Ismaiel, Stefan-Lucian Popa, Flaviu Rusu, Dan L. Dumitrascu. Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review. Medicina 2025; 61(1): 109 doi: 10.3390/medicina61010109
|
| 16 |
Omid Vakili, Peyman Adibi Sedeh, Morteza Pourfarzam. Metabolic biomarkers in irritable bowel syndrome diagnosis. Clinica Chimica Acta 2024; 560: 119753 doi: 10.1016/j.cca.2024.119753
|
| 17 |
Qiaoxia Wang, Xiaoxuan Liu, Dongxing Song, Qingqing Wang, Mengjiao Wu, Zhihao Zhu, Mingxuan Jin, Siqi Liu, Jian Zhang, Rufeng Wang. Exploring the mechanism and effective compounds of Changan Granule on diarrhea-predominant irritable bowel syndrome via regulating 5-hydroxytryptamine signaling pathway in brain-gut axis. Phytomedicine 2025; 136: 156350 doi: 10.1016/j.phymed.2024.156350
|
| 18 |
Silvia Molino, Lorenza Francesca De Lellis, Maria Vittoria Morone, Marcello Cordara, Danaè S. Larsen, Roberto Piccinocchi, Gaetano Piccinocchi, Alessandra Baldi, Alessandro Di Minno, Hesham R. El-Seedi, Roberto Sacchi, Maria Daglia. Improving Irritable Bowel Syndrome (IBS) Symptoms and Quality of Life with Quebracho and Chestnut Tannin-Based Supplementation: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2025; 17(3): 552 doi: 10.3390/nu17030552
|
| 19 |
Ronald L. Koretz. JPEN Journal Club 91. Choosing the population to study. Journal of Parenteral and Enteral Nutrition 2025; doi: 10.1002/jpen.2737
|
| 20 |
Alexey M. Osadchuk, Irina D. Loranskaya, Mikhail A. Osadchuk. Comorbid functional pathology in gastroenterology. Possibilities and prospects for drug treatment: A review. Consilium Medicum 2024; 25(12): 844 doi: 10.26442/20751753.2023.12.202529
|
| 21 |
Olga Biniszewska, Damian Jacenik, Aleksandra Tarasiuk, Jakub Fichna. Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2024; 25(8): 1039 doi: 10.1080/14656566.2024.2366993
|
| 22 |
Jie Liu, Chaolan Lv, Mengqing Yin, Mengtao Zhu, Bo Wang, Jiashuang Tian, Kenji Hashimoto, Yue Yu. Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Constipation-Predominant Irritable Bowel Syndrome: A Single-Center, Single-Blind, Randomized Controlled Trial. American Journal of Gastroenterology 2024; doi: 10.14309/ajg.0000000000003257
|
| 23 |
Michael Cymbal, Arjun Chatterjee, Patricia Ajayi-Fox, Ruishen Lyu, Moises Auron, Brian B. Baggott. Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2025; 60(3): 248 doi: 10.1080/00365521.2025.2456491
|
| 24 |
Juliana Soares Severo, Alda Cássia Alves da Silva, Brenda Lois Barros dos Santos, Thiago Sousa Reinaldo, Aureliano Machado de Oliveira, Rodrigo Soares Pereira Lima, Francisco Leonardo Torres-Leal, Armênio Aguiar dos Santos, Moisés Tolentino Bento da Silva. Physical Exercise as a Therapeutic Approach in Gastrointestinal Diseases. Journal of Clinical Medicine 2025; 14(5): 1708 doi: 10.3390/jcm14051708
|
| 25 |
Yifan Xing, Lee Martin. Is there a sex difference in response to FODMAP diet group education for IBS? A clinical practice service evaluation. Nutrition and Health 2025; doi: 10.1177/02601060251324235
|
| 26 |
Sulaiman A Alshammari, Mohsen N Almutairi, Mohammad O Alomar, Ziyad M Alsherif, Faisal H Alsubaie, Abdulrahman I Almezaini. Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life. Cureus 2023; doi: 10.7759/cureus.50840
|
| 27 |
I.Ya. Hospodarskyy, L.A. Hryshchuk, T.V. Boyko. The possibility of Bacillus probiotic use in patients with post-infectious irritable bowel syndrome after COVID-19 infection. GASTROENTEROLOGY 2024; 58(2): 121 doi: 10.22141/2308-2097.58.2.2024.605
|
| 28 |
C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone. Inflammatory bowel diseases and spondyloarthritis: a focus on female patients. Reumatismo 2024; 76(3) doi: 10.4081/reumatismo.2024.1770
|
| 29 |
Carolina Marques Lopes, Cristina Sofia de Jesus Monteiro, Ana Paula Duarte, Jorge Luiz dos Santos. Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review. Journal of Clinical Medicine 2024; 13(21): 6337 doi: 10.3390/jcm13216337
|
| 30 |
Ophélie Uriot, Charlotte Deschamps, Julien Scanzi, Morgane Brun, Nicolas Kerckhove, Christian Dualé, Elora Fournier, Claude Durif, Sylvain Denis, Michel Dapoigny, Philippe Langella, Monique Alric, Lucie Etienne-Mesmin, Blanquet-Diot Stéphanie. Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL). Bioengineered 2025; 16(1) doi: 10.1080/21655979.2025.2458362
|
| 31 |
Jiangbo Ying, Melvyn Weibin Zhang, Ker-Chiah Wei, Sunny H. Wong, Mythily Subramaniam. Influential articles in autism and gut microbiota: bibliometric profile and research trends. Frontiers in Microbiology 2025; 15 doi: 10.3389/fmicb.2024.1401597
|
| 32 |
Jun Zhao, Xia Li, Jiayi Yang, Xin Hao, Junjian Tian, Xin Wang, Xuefei Wang, Ning Li, Zhigang Li. Prevalence of and factors associated with symptoms consistent with a diagnosis of irritable bowel syndrome among resident physicians in standardised training in China: a cross-sectional study. BMJ Open 2023; 13(12): e079874 doi: 10.1136/bmjopen-2023-079874
|
| 33 |
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new?. Expert Opinion on Drug Metabolism & Toxicology 2024; 20(5): 307 doi: 10.1080/17425255.2024.2348488
|
| 34 |
Vlad Alexandru Ionescu, Gina Gheorghe, Teodor Florin Georgescu, Nicolae Bacalbasa, Florentina Gheorghe, Camelia Cristina Diaconu. The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome. Journal of Clinical Medicine 2024; 13(17): 5124 doi: 10.3390/jcm13175124
|
| 35 |
Liangjun Yang, Zheng Fang, Jiajie Zhu, Xiaofang Li, Bo Yang, Haiyan Liu, Feiyan Lou. The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1464498
|
| 36 |
Jintao Fang, Weihan Zhu, Dian Yu, Lujian Zhu, Haorui Zha, Jingyi Tang, Yujia Li, Xiaxin Zhu, Ting Zhao, Wei Zhang. From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases — Opportunity or Challenge?. Journal of Inflammation Research 2025; : 3349 doi: 10.2147/JIR.S498703
|
| 37 |
Jiaotao Xing, Ying Li, Jiali Hu, Liyao Gu, Guanghua Sun, Xiangle Li. Lateral periaqueductal gray participate in the regulation of irritable bowel syndrome induced by chronic restraint stress. Neurobiology of Disease 2025; 204: 106758 doi: 10.1016/j.nbd.2024.106758
|
| 38 |
Bernhard Uehleke, Martin Storr, Martin Hörning. Grapefruit Seed Extract Reduces Gastrointestinal
Symptoms. Zeitschrift für Phytotherapie 2024; 45(02): 54 doi: 10.1055/a-2194-2206
|
| 39 |
清辉 杜. Exploring Treatment Strategies for Irritable Bowel Syndrome Based on the Concept of “Lung Being Connected with Large Intestine”. Advances in Clinical Medicine 2024; 14(09): 131 doi: 10.12677/acm.2024.1492439
|
| 40 |
Kai-Yue Huang, Jia-Yan Hu, Mi Lv, Feng-Yun Wang, Xiang-Xue Ma, Xu-Dong Tang, Lin Lv. Cerebral cortex changes in FD, IBS, and GERD: A Mendelian randomization study. Journal of Affective Disorders 2025; 369: 1153 doi: 10.1016/j.jad.2024.10.057
|
| 41 |
Wei-Hao Chai, Yan Ma, Jia-Jia Li, Fei Guo, Yi-Zhan Wu, Jiang-Wei Liu. Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study. World Journal of Clinical Cases 2024; 12(17): 3094-3104 doi: 10.12998/wjcc.v12.i17.3094
Abstract(336) |
Core Tip(364) |
Full Article(HTML)(1575)
|
Full Article with Cover (PDF)-9912K(57)
|
Full Article (Word)-1350K(3)
|
Audio-684K(6)
|
Peer-Review Report-195K(43)
|
Answering Reviewers-104K(39)
|
Full Article (PDF)-9454K(63)
|
Full Article (XML)-117K(43)
|
Times Cited (1)
|
Total Visits (4215)
|
Open
|
| 42 |
Michele Linsalata, Antonia Ignazzi, Benedetta D’Attoma, Giuseppe Riezzo, Domenica Mallardi, Antonella Orlando, Laura Prospero, Maria Notarnicola, Valentina De Nunzio, Giuliano Pinto, Francesco Russo. Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet. Nutrients 2024; 16(16): 2706 doi: 10.3390/nu16162706
|